Tech Company Financing Transactions
Viriom Funding Round
On 5/13/2016, Viriom raised $4.7 million in investment from private investors.
Transaction Overview
Company Name
Announced On
5/13/2016
Transaction Type
Venture Equity
Amount
$4,700,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12760 High Bluff Dr. 370
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Viriom Inc. is a late-stage biotech company developing novel and affordable therapies against life threatening infections such as HIV (human immunodeficiency virus). The company has an exclusive worldwide license to its Phase 2/3 stage drug Elpida® and other drug candidates from Hoffmann-La Roche for HIV.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Nikolay Savchuk
Chief Financial Officer
Ronald Demuth
Chief Marketing Officer
Robert Murphy
Vice President
Klaus Klumpp
VP - Bus. Development
Oleg Korzinov
Browse more venture capital transactions:
Prev: 5/13/2016: IRX Therapeutics venture capital transaction
Next: 5/13/2016: Astrobotic venture capital transaction
Share this article
About Database of VC Transactions
We report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs